Study of BMS-587101 in Patients With Moderate to Severe Psoriasis
NCT00162253 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2010-03-02
Summary
The purpose of this clinical research study is to learn if BMS-587101 is effective on the treatment of Moderate to Severe Psoriasis. The safety of this treatment will also be studied.
Conditions
- Psoriasis, Moderate to Severe
Interventions
- DRUG
-
BMS 587101
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-04-30
- Primary Completion
- 2006-06-30
Countries
- United States
Study Locations
More Related Trials
-
Safety Study of BMS-986165 in Healthy Subjects and to Treat Psoriasis
NCT02534636 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male Participants
NCT03004768 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris
NCT00306878 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis
NCT01154101 ·Status: COMPLETED ·Phase: PHASE2
-
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis
NCT03611751 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab in Moderate to Severe Plaque Psoriasis Subjects
NCT01708590 ·Status: TERMINATED ·Phase: PHASE3
-
A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.
NCT02425826 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Study of BMS-986202 in Healthy Subjects and to Treat Psoriasis
NCT02763969 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque Psoriasis
NCT07326813 ·Status: RECRUITING ·Phase: PHASE3
-
An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis
NCT03924427 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Explore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe Psoriasis
NCT01096862 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Randomized, Double-Blind, Placebo-Controlled Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris
NCT00287547 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess Safety, Tolerability, Pharmacokinetic & Pharmacodynamic Effect of UCB5857 in Healthy & Psoriatic Subject
NCT02303509 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
NCT07129382 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe Psoriasis
NCT00001797 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Relative Bioavailability of New Oral Formulations of SRT2104 in Healthy Male Volunteers
NCT01702493 ·Status: COMPLETED ·Phase: PHASE1
-
The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis
NCT05772520 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis
NCT07130604 ·Status: RECRUITING ·Phase: PHASE3
-
VTX958 Versus Placebo for the Treatment of Moderate to Severe Psoriasis
NCT05655299 ·Status: TERMINATED ·Phase: PHASE2
-
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South Korea
NCT04167462 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis
NCT02852967 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Gut Absorption of Experimental Medication BMS-986165 in Healthy Males
NCT03873415 ·Status: COMPLETED ·Phase: PHASE1
-
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
NCT01132612 ·Status: COMPLETED ·Phase: PHASE2
-
P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis
NCT01708603 ·Status: TERMINATED ·Phase: PHASE3
-
SEquential Treatment of PSoriasis With Biologics
NCT07187817 ·Status: RECRUITING